Bent Ejlertsen
Impact in
-
- PARP inhibition in cancer therapy
Papers in
-
- DNA Repair Mechanisms 2
- CRISPR and Genetic Engineering 1
- Oncology 3
- HER2/EGFR in Cancer Research 2
- PARP inhibition in cancer therapy 1
- Co-authors
- Mette Klarskov Andersen (1 shared paper)Finn C. Nielsen (1 shared paper)Lars Jønson (1 shared paper)Thomas van Overeem Hansen (1 shared paper)Birgitte Bertelsen (1 shared paper)Finn Cilius Nielsen (1 shared paper)Claus Storgaard Sørensen (2 shared papers)Grant S. Stewart (1 shared paper)
- Journals
- Journal of Clinical Investigation (2 papers)Acta Oncologica (1 paper)npj Breast Cancer (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- DenmarkUnited KingdomUnited States
In The Last Decade
Bent Ejlertsen
4 papers receiving 45 citations
Peers
Comparison fields: 5 of 18
- Structural Biology 1
- Oncology 17
- Cancer Research 9
- Molecular Biology 39
- Genetics 12
Countries citing papers authored by Bent Ejlertsen
This map shows the geographic impact of Bent Ejlertsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bent Ejlertsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bent Ejlertsen more than expected).
Fields of papers citing papers by Bent Ejlertsen
This network shows the impact of papers produced by Bent Ejlertsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bent Ejlertsen. The network helps show where Bent Ejlertsen may publish in the future.
Co-authors
The 17 scholars most cited alongside Bent Ejlertsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 24 | |
| 2 | 2020 | 20 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2025 | 0 |
About Bent Ejlertsen
Bent Ejlertsen is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 5 papers that have together received 46 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (3 papers), DNA Repair Mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers), Breast Cancer Treatment Studies (1 paper), PARP inhibition in cancer therapy (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Lung Cancer Treatments and Mutations (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Structural Biology (1 citation), Oncology (17 citations), Cancer Research (9 citations), Molecular Biology (39 citations) and Genetics (12 citations). Bent Ejlertsen has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Mette Klarskov Andersen, Finn C. Nielsen, Lars Jønson, Thomas van Overeem Hansen, Birgitte Bertelsen, Finn Cilius Nielsen, Claus Storgaard Sørensen, Grant S. Stewart, Maria Rossing and Heike I. Rösner. Their work appears in journals such as Journal of Clinical Investigation, Acta Oncologica, npj Breast Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.